In biotechnology, timing is everything. Whether advancing a novel therapy or scaling a platform, companies often reach a pivotal point: go public or sell. Increasingly, biotech executives are choosing ...

“Our research innovatively employed a dual-solvent engineering approach within a two-step process to elevate the power conversion efficiency of printable mesoscopic CsPbBr3-based perovskite solar ...

The ups and downs of the M&A and financing markets over the past few years, particularly in the emerging companies (EC) and venture capital (VC) sector, have demonstrated the importance of emerging ...